cisatracurium apotex cisatracurium (as besilate) 20 mg / 10 ml solution for injection ampoule
arrotex pharmaceuticals pty ltd - cisatracurium besilate, quantity: 2.68 mg/ml - injection, solution - excipient ingredients: water for injections; benzenesulfonic acid - cisatracurium injection is indicated for use during surgical and other procedures and in intensive care to relax skeletal muscles, and to facilitate tracheal intubation and mechanical ventilation. it is used as an adjunct to general anaesthesia, or sedation in the intensive care unit.
cisatracurium-aft
aft pharmaceuticals ltd - cisatracurium besilate 0.268%{relative} equivalent to cisatracurium 0.2% w/v - solution for injection - 2 mg/ml - active: cisatracurium besilate 0.268%{relative} equivalent to cisatracurium 0.2% w/v excipient: benzenesulfonic acid water for injection - cisatracurium-aft is indicated for use during surgical and other procedures and in intensive care to relax skeletal muscles, and to facilitate tracheal intubation and mechanical ventilation. it is used as an adjunct to general anaesthesia, or sedation in the intensive care unit.
cisatracurium-aft
aft pharmaceuticals ltd - cisatracurium besilate 0.669%{relative} equivalent to cisatracurium 0.5% w/v - solution for injection - 5 mg/ml - active: cisatracurium besilate 0.669%{relative} equivalent to cisatracurium 0.5% w/v excipient: benzenesulfonic acid water for injection - cisatracurium-aft is indicated for use during surgical and other procedures and in intensive care to relax skeletal muscles, and to facilitate tracheal intubation and mechanical ventilation. it is used as an adjunct to general anaesthesia, or sedation in the intensive care unit.
cisatracurium hhh cisatracurium (as besilate) 20mg/10ml solution for injection ampoule
juno pharmaceuticals pty ltd - cisatracurium besilate -
cisatracurium hhh cisatracurium (as besilate) 150mg/30ml solution for injection vial
juno pharmaceuticals pty ltd - cisatracurium besilate -
cisatracurium hhh cisatracurium (as besilate) 5mg/2.5ml solution for injection ampoule
juno pharmaceuticals pty ltd - cisatracurium besilate -
cisatracurium hhh cisatracurium (as besilate) 10mg/5ml solution for injection ampoule
juno pharmaceuticals pty ltd - cisatracurium besilate -
cisatracurium ajs cisatracurium (as besilate) 150mg/30ml injection solution in vial
southern cross pharma pty ltd - cisatracurium besilate, quantity: 6.7 mg/ml (equivalent: cisatracurium, qty 5 mg/ml) - injection, solution - excipient ingredients: benzenesulfonic acid; water for injections - during surgical and other procedures and in intensive care to relax skeletal muscles, and to faciliate tracheal intubation and mechanical ventilation. an adjunct to general anaesthesia, or sedation in intensive care units
cisatracurium ajs cisatracurium (as besilate) 20mg/10ml injection solution in vial
southern cross pharma pty ltd - cisatracurium besilate, quantity: 2.68 mg/ml (equivalent: cisatracurium, qty 2 mg/ml) - injection, solution - excipient ingredients: benzenesulfonic acid; water for injections - during surgical and other procedures and in intensive care to relax skeletal muscles, and to faciliate tracheal intubation and mechanical ventilation. an adjunct to general anaesthesia, or sedation in intensive care units
cisatracurium ajs cisatracurium (as besilate) 10mg/5ml injection solution in vial
southern cross pharma pty ltd - cisatracurium besilate, quantity: 2.68 mg/ml (equivalent: cisatracurium, qty 2 mg/ml) - injection, solution - excipient ingredients: benzenesulfonic acid; water for injections - during surgical and other procedures and in intensive care to relax skeletal muscles, and to faciliate tracheal intubation and mechanical ventilation. an adjunct to general anaesthesia, or sedation in intensive care units.